Corient Private Wealth’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Corient Private Wealth’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,884	Closed	-$766K	–	2860
2025 Q4	$766K	Buy	50,884 +30,442	+149%	+$457K	﹤0.01%	2044
2025 Q3	$295K	Hold	20,442	–	–	﹤0.01%	2128
2025 Q2	$292K	Buy	20,442 +4,417	+28%	+$63.1K	﹤0.01%	2007
2025 Q1	$239K	Sell	16,025 -10,200	-39%	-$160K	﹤0.01%	1974
2024 Q4	$378K	Buy	26,225 +5,224	+25%	+$80.9K	﹤0.01%	1774
2024 Q3	$333K	Sell	21,001 -34,211	-62%	-$540K	﹤0.01%	1968
2024 Q2	$848K	Buy	55,212 +84	+0.2%	+$1.27K	﹤0.01%	1391
2024 Q1	$893K	Buy	55,128 +29,103	+112%	+$459K	﹤0.01%	1348
2023 Q4	$381K	Buy	26,025 +16,025	+160%	+$224K	﹤0.01%	1755
2023 Q3	$144K	Buy	+10,000	New	+$156K	﹤0.01%	1979
2023 Q1	–	Sell	-11,153	Closed	-$172K	–	2010
2022 Q4	$172K	Buy	+11,153	New	+$173K	﹤0.01%	1513

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Corient Private Wealth's BMEZ Position: Q1 2026 in Review

Corient Private Wealth sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2026, closing a stake of 50,884 shares — an estimated $766K sold.

Corient Private Wealth first reported a position in BMEZ in Q4 2022 and held it in 11 quarters. The position peaked at $893K in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

Corient Private Wealth reported no remaining BlackRock Health Sciences Trust II position as of Q1 2026 after selling out during the quarter.
Corient Private Wealth sold 50,884 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $766K.
Corient Private Wealth first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 11 quarters.
Corient Private Wealth's BlackRock Health Sciences Trust II position peaked at $893K in Q1 2024.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.